HINYE Trademark

Trademark Overview


On Friday, September 25, 2020, a trademark application was filed for HINYE with the United States Patent and Trademark Office. The USPTO has given the HINYE trademark a serial number of 79304188. The federal status of this trademark filing is REGISTERED as of Tuesday, September 21, 2021. This trademark is owned by Hinye Pharmaceutical Co.,Ltd.. The HINYE trademark is filed in the Pharmaceutical Products category with the following description:

Herbal supplements; medicinal herbal preparations; medicinal herbs; herbs for medicinal purposes; chinese traditional medicinal herbs; medicinal herbal extracts for medical purposes; medicines for the treatment of gastrointestinal diseases; antiallergic medicines; medicines for alleviating constipation; pharmaceutical preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; pharmaceutical preparations for the prevention of cardiovascular disorders, cardiopulmonary disorders, neurological disorders,...
hinye

General Information


Serial Number79304188
Word MarkHINYE
Filing DateFriday, September 25, 2020
Status700 - REGISTERED
Status DateTuesday, September 21, 2021
Registration Number6488785
Registration DateTuesday, September 21, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements


Goods and ServicesHerbal supplements; medicinal herbal preparations; medicinal herbs; herbs for medicinal purposes; chinese traditional medicinal herbs; medicinal herbal extracts for medical purposes; medicines for the treatment of gastrointestinal diseases; antiallergic medicines; medicines for alleviating constipation; pharmaceutical preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; pharmaceutical preparations for the prevention of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; unit dose capsules sold empty for pharmaceutical use; biological preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; allergy tablets; antibiotic tablets
Translation of Words in MarkThe wording "HINYE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHinye Pharmaceutical Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameHinye Pharmaceutical Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameHinye Pharmaceutical Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Monday, April 4, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 10, 2022FINAL DISPOSITION PROCESSED
Tuesday, December 21, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 21, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 29, 2021REFUSAL PROCESSED BY IB
Friday, March 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 5, 2021REFUSAL PROCESSED BY MPU
Saturday, February 27, 2021APPLICATION FILING RECEIPT MAILED
Thursday, February 25, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 24, 2021NON-FINAL ACTION WRITTEN
Tuesday, February 23, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 18, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB